FNCHQ
Finch Therapeutics Group, Inc.Company with tickers: FNCH, FNCHQ
CIK
1733257
CUSIP
31773D200
Shares Outstanding
1,605,763
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-17 | 2023-11-15 | |
| 8-K | 2024-02-23 | 2024-02-16 | |
| 10-K | 2024-03-25 | 2023-12-31 | |
| 8-K | 2024-04-03 | 2024-03-28 | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-17 | 2024-05-14 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-08-12 | 2024-08-09 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-10-21 | 2024-10-17 |
Showing 51–62 of 62 filings